These countries are also experiencing increasing urbanization and subsequent access to modern retail, as well as slowly improving regulatory environments that may alter the market landscape.

These trends create a “pharmerging” growth dynamic likely to affect pharmaceutical sales in the region for years to come.

Download the complete report for more information. The growth of the pharmaceutical industry in LatAm is parallel to the growing demand for medical devices across the region. Companies can take advantage of this by subscribing to GHI’s Latin American hospitals database, the world’s largest, as well as by exploring custom research services to edge out competitors or identify market share in different verticals.